Break into the MedTech industry with Meet&Match.Dx!

28th June 2022

Are you interested in collaborating with leading MedTech companies to tackle diagnostic challenges and open the path for partnership exploration? Join the Meet & Match.Dx, a challenge-based acceleration programme that connects SMEs developing breakthrough diagnostic solutions with major pharmaceutical and medical technology companies in Europe through tailored workshops and one-to-one pitch sessions, with the aim to explore partnership opportunities.

The Meet & Match.Dx programme is a challenge-based acceleration programme within the Codex4SMEs project that connects SMEs developing breakthrough diagnostic solutions with major pharmaceutical and medical technology companies in Europe through tailored workshops, unparalleled exposure to industry executives and decision makers and one-to-one pitching sessions, with the aim to explore partnership opportunities.

2022 Challenges:

  1. Non-invasive tools to measure nutrient status in children and adults in collaboration with Abbott
  2. Accurate, real-time visualization of tumors during oncology resection surgeries in collaboration with Medtronic
  3. Point-of-care test for allergy in collaboration with ThermoFisher Scientific
  4. Disruptive solutions for early disease idenification and interdisciplinary treatment of eosinophilic diseases in collaboration with GlaxoSmithKline GmbH & Co. KG

Full description of the challenges is available here.

Webinars to get more info about the programme and the application process: 

Application deadline: Fill in the application form and send it to [email protected] until 28 August 2022, 23:59 CET.

If you are developing innovative technologies and products representing potential solutions for the selected challenges for 2022, submit your application now!

More information: The Meet&Match.Dx programme managed by EIT Health is part of the Interreg NWE-funded Codex4SMEs project. Since 2017, Codex4SMEs has built a large European network in the field of diagnostics and personalized medicine. More than 300 small and medium-sized enterprises have so far benefited from the opportunities offered. These include various events and tailored services that support SMEs in the development of innovative diagnostics.

Recent posts
EnglishFrenchItalianPortugueseSpanish